Immupharma Share Discussion Threads

[lord loads of lolly] 27/9/2022 14:28

nobby - you told us you'd sold out immediately after the FDA's announcement, so why are you bothered? In fact, some might question why you're still posting here at all?

[nobbygnome] 27/9/2022 11:48

Conspiratorial nonsense….

[david gruen] 26/9/2022 11:14

You deal in tiny volumes Dilly. I have to go through an accumulation phase.

[david gruen] 26/9/2022 10:46

We flushed out the mugs, we took their shares for a pittance, we now freeze them out.

Rinse and repeat!

[mcdermov] 26/9/2022 10:44

No RNS and a little bounce this am. Good trading opportunity?

[nobbygnome] 23/9/2022 20:36

Is McCarthy in prison yet…

[ken chung] 23/9/2022 09:16

A fine short.Lemmings and mushrooms only.

[colsmith] 16/9/2022 09:16

Now its GMO shots like the mRna that's been about for billions to take! Re SK's post above.

"Five people with severe autoimmune disease have become the first in the world to receive a groundbreaking therapy that uses genetically altered cells to drive the illness into remission"

[david gruen] 16/9/2022 07:46

Good news for HEMO!

[nobbygnome] 16/9/2022 07:15

Really good to see this step forward but the expense of this sort of treatment means it won’t be available to the masses

[bob1995] 16/9/2022 01:14

Yep. Looks like a German company has jumped ahead

[pretax2] 14/9/2022 21:05

May I humbly suggest taking a look at Plant Health Care (PHC) to get your money back in the next two years. Their plant biostimulants do work - brilliantly. They substantially increasing yields for growers, they're growing big time globally, no more raises and looking towards $30m sales by 2025. The climate change and sustainability agenda, as well as a growing food crisis with high fertilizer costs and increasing competiion for land from Bio fuels, are helping the stars align. Oh, and the shareprice hasn't broken out yet, but the heard are gathering slowly. Investors only, this isn't an overnight boom and bust share.




Just a suggestion, no pump intended (or needed really). If you're not interested, please continue the fight here.
Usual caveats apply. DYOR.

[colsmith] 14/9/2022 17:09

Not really of relevance but shows something I'm not sure what. In my post 38302 I referred to Lupuzor being not FDA approved in USA but it was in Japan and EU; well clearly its not approved anywhere. I meant it is Flutiform, developed by SKYEPHARMA years ago. Link 2 shows countries where it is available and USA not listed. Link 1 shows FDA wanted more info such as:

"it appears likely that some additional clinical work may be required to provide more data on dosing."

So strangely worldwide its OK and works but in USA it doesn't unless things have changed. Seems to me IMM should have sought approval elsewhere, where maybe the swamp isn't so deep. Anyhow over and out until this implodes, get taken out or is a phoenix which it just might be but timescale not clear.

The company needs to make clear the path to P3 rather than leaving the market wonder what its all about!

PS - guy fawkes on 38318 seems to have point!

[lord loads of lolly] 14/9/2022 12:34

Eva Perón - Oh dear - looks like it's Greasy Spoon now, rather than Starbucks. Sigh. Still, chin up. As per your post from yesterday, you’ve only £255k invested here. Not.

[waterloo01] 14/9/2022 12:10

FDA have basically said we don't like the dose and we don't like the protocol. However Tim spins it, it's back to the drawing board. It will be months before you find out. Meanwhile the death spiral will slowly kill this.

[colsmith] 14/9/2022 12:03

I suppose the bigger worry is - the emergency approval (whatever that means) for the COVID stuff was sent through at F1 speed and it is apparently all OK. So why for a minor is the FDA that concerned? All strange - is it smoke and mirrors for any approval? Oh well have good day, not much to post for now.